Department of Thoracic Surgery, University Hospital Basel, Basel, Switzerland.
Interact Cardiovasc Thorac Surg. 2022 Feb 21;34(3):386-392. doi: 10.1093/icvts/ivab278.
First experiences with rib fixation using nitinol, in terms of reliability and morbidity, influence on pain control and quality of life (QOL), in a large series of selected patients after blunt chest trauma.
Data of all patients who had undergone rib fixation by the use of nitinol were retrospectively analysed in terms of indications, morbidity and in-hospital mortality. Pain status and health-related QOL were assessed preoperatively, when possible, at discharge and at 1, 3, 6 and 12 months post-surgery using visual analogous scale and short form 12 questionnaires.
From September 2017 to April 2019, 70 patients underwent rib fixation using the nitinol device, of which 47 (67%) had dislocated, painful fractures, 6 (8.5%) had flail chest injuries, 6 (8.5%) were emergencies with haemodynamical instability and 11 (16%) had pseudoarthrosis. Morbidity was 21% without wound infection; in-hospital mortality was 3%. Fracture of the material occurred in 6% of the patients during the first year, but removal of the material was not required. Analysis of the pain score showed a statistically significant decrease in pain for both the whole collective and the group with a series of dislocated and painful fractured ribs (P < 0.001, Tukey contrast on the linear mixed-effects models). Assessment of health-related QOL revealed a significant improvement in the physical score for the mid- and long-term analysis.
Our results suggest that rib fixation using the nitinol device is reliable, associated with an acceptable morbidity, while significantly decreasing pain and improving health-related QOL.
本研究旨在评估钝性胸部创伤患者中,使用镍钛诺肋骨固定的初步经验,包括可靠性和发病率、对疼痛控制和生活质量(QOL)的影响。
回顾性分析 2017 年 9 月至 2019 年 4 月期间,所有使用镍钛诺进行肋骨固定的患者的资料,包括适应证、发病率和院内死亡率。在术前、出院时以及术后 1、3、6 和 12 个月,使用视觉模拟量表和简明健康状况调查问卷评估疼痛状况和健康相关 QOL。
70 例患者接受了镍钛诺装置的肋骨固定术,其中 47 例(67%)为有移位、疼痛性骨折,6 例(8.5%)为连枷胸损伤,6 例(8.5%)为有血流动力学不稳定的急症,11 例(16%)为假关节。发病率为 21%,无伤口感染;院内死亡率为 3%。在第一年,有 6%的患者发生了材料骨折,但不需要取出材料。疼痛评分分析显示,整个患者群体和一系列有移位、疼痛性骨折的患者群体的疼痛均有显著下降(P<0.001,线性混合效应模型的 Tukey 对比)。健康相关 QOL 的评估显示,在中、长期分析中,生理评分有显著改善。
镍钛诺肋骨固定术可靠,发病率可接受,可显著减轻疼痛,改善健康相关 QOL。